Search research articles
Contact Us
Filters
Showing results (11-20 of 50) with videos related to
Page
of 5
Sort By:
Investigational New Drugs
|
January 1, 1985
A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study
E Eisenhauer, I Quirt, J M Connors, et al.
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC
|
October 10, 1998
Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group
A Figueredo, S Fine, J Maroun, et al.
Annales De Chirurgie
|
January 1, 1993
[Treatment of sclerodermic esophagitis: value of duodenal diversion]
J L Peix, J Maroun, O Tekinel, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
October 1, 1995
Effects of physical conditioning on endogenous nitric oxide output during exercise
M J Maroun, S Mehta, R Turcotte, et al.
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC
|
October 10, 1998
Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group
A Figueredo, C Germond, J Maroun, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Multicenter phase II study of brequinar sodium in patients with advanced lung cancer
J Maroun, J Ruckdeschel, R Natale, et al.
Cancer
|
August 1, 1980
Evaluation of vindesine and MER in colorectal cancer
A Y Bedikian, M Valdivieso, J Maroun, et al.
Anticancer Research
|
January 1, 1991
The effect of lonidamine alone and in combination with cisplatin on in vitro growth and viability of lung squamous cell carcinoma cell lines
G P Raaphorst, D Ko, M M Feeley, et al.
Investigational New Drugs
|
February 1, 1993
Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer
M Moore, J Maroun, F Robert, et al.
Current Oncology (Toronto, Ont.)
|
January 4, 2020
A retrospective observational study to estimate the attrition of patients across lines of systemic treatment for metastatic colorectal cancer in Canada
H Kennecke, S Berry, J Maroun, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 50) with videos related to
Sort By:
Page
of 5
Investigational New Drugs
|
January 1, 1985
A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study
E Eisenhauer, I Quirt, J M Connors, et al.
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC
|
October 10, 1998
Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group
A Figueredo, S Fine, J Maroun, et al.
Annales De Chirurgie
|
January 1, 1993
[Treatment of sclerodermic esophagitis: value of duodenal diversion]
J L Peix, J Maroun, O Tekinel, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
October 1, 1995
Effects of physical conditioning on endogenous nitric oxide output during exercise
M J Maroun, S Mehta, R Turcotte, et al.
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC
|
October 10, 1998
Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group
A Figueredo, C Germond, J Maroun, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Multicenter phase II study of brequinar sodium in patients with advanced lung cancer
J Maroun, J Ruckdeschel, R Natale, et al.
Cancer
|
August 1, 1980
Evaluation of vindesine and MER in colorectal cancer
A Y Bedikian, M Valdivieso, J Maroun, et al.
Anticancer Research
|
January 1, 1991
The effect of lonidamine alone and in combination with cisplatin on in vitro growth and viability of lung squamous cell carcinoma cell lines
G P Raaphorst, D Ko, M M Feeley, et al.
Investigational New Drugs
|
February 1, 1993
Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer
M Moore, J Maroun, F Robert, et al.
Current Oncology (Toronto, Ont.)
|
January 4, 2020
A retrospective observational study to estimate the attrition of patients across lines of systemic treatment for metastatic colorectal cancer in Canada
H Kennecke, S Berry, J Maroun, et al.
Page
of 5